Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Crossover Oral Bioavailability Study Comparing the Pharmacokinetics and Pharmacodynamics of Picoplatin Administered Orally With Picoplatin Administered Intravenously in Subjects With Advanced Non-Hematological Malignancies

NCT00465725 is registered in ClinicalTrials.gov with Poniard Pharmaceuticals as lead sponsor.

NCT NCT00465725
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00465725 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Crossover Oral Bioavailability Study Comparing the Pharmacokinetics and Pharmacodynamics of Picoplatin Administered Orally With Picoplatin Administered Intravenously in Subjects With Advanced Non-Hematological Malignancies
Lead sponsor
Poniard Pharmaceuticals
Phase
Phase 1
Overall status
Completed
Start date
April 30, 2007
Completion date
July 31, 2009
Enrollment
18 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer, breast cancer, colorectal cancer, gastrointestinal neoplasm, head and neck cancer, lung cancer, ovarian cancer, pancreatic cancer, prostate cancer